Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double‐blind, placebo‐controlled trial with microbiome analysis

Study answer

What this study found

Oral probiotic supplementation from early pregnancy did not meaningfully change vaginal microbiota or bacterial vaginosis outcomes. At 18 to 20 weeks' gestation, bacterial vaginosis occurred in 15% (19/123) of the probiotic group versus 9% (10/115) of placebo, with an adjusted OR of 1.82 (95% CI 0.64-5.19; P = 0.26). Vaginal colonization by L. rhamnosus GR-1 was only 5% (6/123) in the probiotic arm and 5% (6/115) in placebo, while L. reuteri RC-14 was not detected in either group. Alpha diversity and community composition did not differ significantly, and no serious adverse events related to…

Study & population

Randomized, double-blind, placebo-controlled trial with vaginal microbiome analysis in pregnant women enrolled at 9 to 14 weeks' gestation.

Intervention

Oral probiotic capsules containing Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14, 2.5 billion CFUs of each strain per capsule, were taken once daily from recruitment until delivery.

Key limitation

The primary analysis included fewer participants than were randomized in the probiotic arm, and the intervention showed very low vaginal colonization, limiting biological signal detection.

View full study detailsView sourceOpen PDF

Original abstract